Skip To Main Content
Lilly
Menu closed
Lilly
  • Medical Home
    • Medical Information
Chat Click to chat
Question Submit a question

Information Request

Lilly Rep Request

Expand contact lilly
Lilly

You are now leaving the LillyMedical website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Eli Lilly and Company does not control, influence, or endorse this site, and the opinions, claims or comments expressed on this site should not be attributed to Eli Lilly and Company. Eli Lilly and Company is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

  1. Home Medical Right
  2. Medical Information Right
  3. Verzenios ® (abemaciclib) Right
  4. Should other citrus fruits be avoided with Verzenios® (abemaciclib) apart from grapefruit?
Search abemaciclib information
Search Medical Information


Tips for searching:

• You have to select a product and type at least 2 words to activate the search
• Use only words that are specific to the information you are looking for
• Avoid typing questions or sentences

Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow card in the Google play or Apple app store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.

Verzenios ® (abemaciclib)

This information is intended for UK registered healthcare professionals only in response to your search for information. For current information for all Lilly products, including Summaries of Product Characteristics, Patient Information Leaflets and Instructions for Use, please visit: www.medicines.org.uk

Back to search result(s)

Should other citrus fruits be avoided with Verzenios® (abemaciclib) apart from grapefruit?

Furanocoumarins in grapefruit and its juice inhibit CYP34A, the enzyme metabolising abemaciclib. Seville oranges, limes and pomelos can also contain high levels of furanocoumarins, while sweet oranges contain little or no levels.

UK_cFAQ_ABE2005_GRAPEFRUIT_CITRUS_ORANGE
UK_cFAQ_ABE2005_GRAPEFRUIT_CITRUS_ORANGEen-GB

Verzenios is a substrate of CYP3A4

Abemaciclib is primarily metabolised by CYP3A4. Below you will find information about the use of strong CYP3A4 inhibitors together with abemaciclib. Please review the Verzenios Summary of Product Characteristics, particularly the sections: 

• 4.2 Posology and method of administration 

• 4.5 Interaction with other medicinal products and other forms of interaction


Although the pharmacokinetic interactions of abemaciclib with citrus fruits have not been systematically evaluated, the following data about interactions of CYP3A4 substrates with citrus fruits may inform your clinical decision.

Grapefruit and its juice inhibits CYP3A4

Grapefruit and its juice contain furanocoumarins, such as bergamottin, epoxybergamottin, and 6′,7′-dihydroxybergamottin that inhibit the CYP3A4 enzyme.1 

One whole grapefruit or 200 mL of grapefruit juice is sufficient to cause clinically relevant increased systemic drug concentration and subsequent adverse effects.2

All parts of the fruit (freshly squeezed juice, frozen concentrate and whole fruit) have the potential to reduce the activity of CYP3A4.3,4

Seville oranges, limes and pomelos also contain furanocoumarins

Other citrus fruits like Seville oranges, pomelos and limes contain relatively high levels of furanocoumarins.5-7

Are sweet oranges and mandarins safe to eat?

Sweet oranges, mandarins and mandarin hybrids contains little or no furanocoumarins and will not affect the activity of CYP3A4.8 

It is essential to know that many citrus fruits, including oranges, are cross-bred and can contain furanocoumarins and therefore impact CYP3A4. 

References

1Hung WL, Suh JH, Wang Y. Chemistry and health effects of furanocoumarins in grapefruit. J Food Drug Anal. 2017;25(1):71-83. https://doi.org/10.1016/j.jfda.2016.11.008

2Bailey DG, Dresser G, Arnold JM. Grapefruit-medication interactions: forbidden fruit or avoidable consequences?. CMAJ. 2013;185(4):309-316. doi:10.1503/cmaj.120951.

3Edgar B, Bailey D, Bergstrand R, Johnsson G, Regårdh CG. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine--and its potential clinical relevance. Eur J Clin Pharmacol. 1992;42(3):313-317. doi:10.1007/BF00266354.

4Bailey DG, Dresser GK, Kreeft JH, Munoz C, Freeman DJ, Bend JR. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients. Clin Pharmacol Ther. 2000;68(5):468-477. doi:10.1067/mcp.2000.110774.

5Malhotra S, Bailey DG, Paine MF, Watkins PB. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther. 2001;69(1):14-23. https://doi.org/10.1067/mcp.2001.113185

6Guo LQ, Chen QY, Wang X, et al. Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine. Curr Drug Metab. 2007;8(6):623-630. https://doi.org/10.2174/138920007781368917

7Masuda M, Watanabe S, Tanaka M, et al. Screening of furanocoumarin derivatives as cytochrome P450 3A4 inhibitors in citrus. J Clin Pharm Ther. 2018;43(1):15-20. https://doi.org/10.1111/jcpt.12595

8Dugrand-Judek A, Olry A, Hehn A, et al. The Distribution of Coumarins and Furanocoumarins in Citrus Species Closely Matches Citrus Phylogeny and Reflects the Organization of Biosynthetic Pathways. PLoS One. 2015;10(11):e0142757. Published 2015 Nov 11. doi:10.1371/journal.pone.0142757.

Links to references and third-party websites are provided solely for your convenience and to facilitate easy access to the sources cited.

Date of Last Review: 06 October 2023

Was this answer helpful?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms and conditions
  • Privacy Policy & Cookies
  • Accessibility Information
  • Cookie settings

    MI-LM-UK-1012 May-2025 | ® Registered Trademark of Eli Lilly and Company | © Eli Lilly and Company 2025.

    This site is published by Eli Lilly and Company Ltd and is intended for Healthcare Professionals in the United Kingdom

    Lilly